Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Emergency room visits for asthma and the reported outcomes: The PASS survey by the CRISALIS network].

Revue des maladies respiratoires·2025
Same author

Brain Charts for the Rhesus Macaque Lifespan.

bioRxiv : the preprint server for biology·2024
Same author

Safety and effectiveness of laparoscopic adult groin hernia repair in Africa: a systematic review and meta-analysis.

Hernia : the journal of hernias and abdominal wall surgery·2024
Same author

Validation of the revised HOME-CoV rule to safely discharge patients with COVID-19: a multicenter prospective cohort.

Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias·2023
Same author

Adult groin hernia surgery in sub-Saharan Africa: a 20-year systematic review and meta-analysis.

Hernia : the journal of hernias and abdominal wall surgery·2022
Same author

[Caracteristics Of Severe Malaria In Child From 0 To 5 Years At The Hospital Of Sikasso In Mali].

Le Mali medical·2022

Related Experiment Videos

[Ventilator-associated pneumonia: follow the guidelines!].

B Jung1, M Sebbane, G Chanques

  • 1Unité de réanimation et de transplantation, département d'anesthésie-réanimation B, CHU de Montpellier, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier, France.

Annales Francaises D'Anesthesie Et De Reanimation
|August 19, 2007
PubMed
Summary

Early and late ventilator-associated pneumonia (VAP) are often caused by multidrug-resistant bacteria. Clinicians should consider resistant pathogens in all VAP cases, regardless of onset time.

Related Experiment Videos

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Microbiology

Context:

  • Ventilator-associated pneumonia (VAP) is a significant nosocomial infection.
  • Distinguishing between early-onset and late-onset VAP is crucial for treatment strategies.
  • Bronchoalveolar lavage (BAL) is a key diagnostic tool for VAP.

Purpose:

  • To compare the clinical outcomes and causative pathogens of early-onset versus late-onset VAP.
  • To identify the prevalence of multiresistant pathogens in different VAP onset groups.

Summary:

  • A 7-year prospective study analyzed 113 VAP cases diagnosed by BAL.
  • Multiresistant pathogens were found in 34% of early-onset VAP and 73% of late-onset VAP.
  • Pseudomonas aeruginosa was the most common pathogen in both groups; morbidity and mortality were similar.

Impact:

  • Findings suggest that early-onset VAP also frequently involves multiresistant bacteria.
  • Highlights the need for vigilance regarding resistant pathogens in all VAP cases.
  • Informs empirical antibiotic selection and infection control protocols for VAP.